MS4A2

MS4A2 encodes the β-chain of the high-affinity IgE receptor (FcεRI) on mast cells and basophils, where it is essential for receptor surface expression and IgE-mediated degranulation. Transcription of MS4A2 is directly activated by GATA2, which binds the proximal promoter (~−60 bp) and cooperates with PU.1 and the chromatin looping factor LDB1 at a +10.4-kbp downstream enhancer; CRISPR deletion of this enhancer completely abolishes MS4A2 expression and FcεRI surface display (PMID:24639354, PMID:31501274). A common −109T/C promoter polymorphism modulates MS4A2 transcriptional output, with the −109T allele driving higher promoter activity in reporter assays (PMID:16839402).

1. 2006 Medium

   Establishing that cis-regulatory variation directly modulates MS4A2 transcription: the −109T/C promoter polymorphism was shown to alter promoter activity, providing the first direct evidence that MS4A2 expression is controlled at the transcriptional level by specific promoter elements.

   Evidence Luciferase reporter assays comparing −109T and −109C allele constructs in RBL-2H3 mast cells and A549 epithelial cells

   PMID:16839402

   Open questions at the time

   • Reporter assay in cell lines; endogenous chromatin context not tested
   • Transcription factor(s) differentially binding the −109 site not identified
   • Functional consequence on FcεRI surface expression or degranulation not measured
2. 2009 Low

   Corroborating the functional relevance of promoter polymorphisms in vivo: haplotype analysis in human subjects linked the −109T allele and −752C/T variant to differences in FcεRIβ transcript abundance in peripheral blood, connecting promoter variation to endogenous gene expression.

   Evidence Quantitative RT-PCR of FcεRIβ mRNA correlated with genotype/haplotype in human peripheral blood samples

   PMID:19218813

   Open questions at the time

   • Correlative genotype–expression association without direct functional manipulation
   • Cell-type-specific contribution (mast cells vs. basophils vs. other leukocytes) not resolved
   • No causal editing of the polymorphic site performed
3. 2014 High

   Identifying GATA2 as the master transcriptional activator of MS4A2 in human mast cells: GATA2 was shown to directly bind the MS4A2 promoter and transactivate it, and its knockdown reduced β-chain mRNA and suppressed IgE-mediated degranulation, linking transcription factor identity to receptor function.

   Evidence ChIP, EMSA, luciferase reporter assays, siRNA knockdown of GATA2 with flow cytometry for FcεRI surface expression and degranulation assay in human mast cells

   PMID:24639354

   Open questions at the time

   • Enhancer elements beyond the proximal promoter not yet mapped
   • Cofactors cooperating with GATA2 at the MS4A2 locus not defined
   • Mechanism by which β-chain loss impairs degranulation (assembly vs. signaling) not dissected
4. 2019 High

   Defining the full cis-regulatory architecture of MS4A2: a +10.4-kbp enhancer was identified where GATA2 and PU.1 co-bind with the looping factor LDB1, and its CRISPR deletion completely abolished MS4A2 expression and FcεRI surface display, establishing that both proximal promoter and distal enhancer are required.

   Evidence ChIP for GATA2/PU.1/LDB1, CRISPR deletion of +10.4-kbp enhancer region, flow cytometry, and gene expression analysis in mouse bone-marrow-derived mast cells

   PMID:31501274

   Open questions at the time

   • Physical chromatin looping between the enhancer and promoter not directly demonstrated (e.g., 3C/Hi-C)
   • Whether LDB1 is required or merely present at the enhancer not tested by loss-of-function
   • Relevance of the +10.4-kbp enhancer in human mast cells not confirmed

• It remains unknown how FcεRIβ (MS4A2) mechanistically amplifies FcεRI signaling at the molecular level, whether additional distal regulatory elements control MS4A2 in basophils versus mast cells, and how the −109T/C polymorphism intersects with GATA2-dependent activation in the native chromatin context.
• Structural basis by which β-chain four-transmembrane topology enhances receptor complex signaling is unresolved
• Basophil-specific transcriptional regulation of MS4A2 is largely uncharacterized
• No integrative model combining promoter polymorphisms with GATA2/PU.1/LDB1 enhancer regulation in human cells